At the completion of this program, the participant will be able to:- identify the role of new oral therapies in treating chronic hepatitis C (HCV) infection;- recognize management strategies for drug interactions and side effects of new HCV therapies;- understand cost concerns of new HCV therapies;- identify the pharmacist's role in managing patients who are undergoing HCV treatment.